Therefore, these data support a notion that USP9X-mediated deubiquitination of KDM4C stimulates the activation of the TGF-β2/Smad/ATM signaling, and eventually contributes to radioresistance in lung cancer. Here, KDM4C is linked to lung carcinoma.